Skip to main content
Journal of Korean Medical Science logoLink to Journal of Korean Medical Science
. 2000 Apr;15(2):243–246. doi: 10.3346/jkms.2000.15.2.243

Myelomatous effusion with poor response to chemotherapy.

Y M Kim 1, K K Lee 1, H S Oh 1, S K Park 1, J H Won 1, D S Hong 1, H S Park 1, J S Park 1, D W Lee 1
PMCID: PMC3054621  PMID: 10803706

Abstract

While pleural effusion in multiple myeloma is relatively infrequent, myelomatous pleural effusion is extremely rare. We experienced a 61-year-old woman with IgD-lambda multiple myeloma and pleural effusion. The diagnosis was made originally by pleural biopsy, pleural fluid cytology and immunoelectropheresis of pleural fluid. Transient improvement of the pleural effusion was observed after administration of combination chemotherapy of vincristine, melphalan, cyclophosphamide, prednisone (VMCP)/vincristine, cyclophosphamide, adriamycin, prednisone (VCAP). Two months later, myelomatous pleural effusion recurred and no response to salvage therapy was observed. We reviewed the clinical feature of this case and literature concerning myelomatous pleural effusion.

Full Text

The Full Text of this article is available as a PDF (428.9 KB).


Articles from Journal of Korean Medical Science are provided here courtesy of Korean Academy of Medical Sciences

RESOURCES